Appeal against Alzheimer's drug decision

By Charlotte2007-10-04T09:00:00

Pharmaceutical companies are appealing a High Court judgement that upheld the National Institute for Health and Clinical Excellence's decision to restrict the use of anti-dementia medicines for NHS patients in the early stages of Alzheimer's disease.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here